Scientists Working Toward Reversible Kind of Gene Editing - NBC 7 San Diego
National & International News
The day’s top national and international news

Scientists Working Toward Reversible Kind of Gene Editing

A genome editing technique called CRISPR has revolutionized scientific research

    processing...

    NEWSLETTERS

    Smart Home Technologies That Are Changing the Game
    AP/Susan Walsh
    In this December 1, 2015 file photo, University at California Berkeley biochemist and founding member of CRISPR Jennifer Doudna speaks at the National Academy of Sciences international summit on the safety and ethics of human gene editing in Washington.

    Scientists are altering a powerful gene-editing technology in hopes of one day fighting diseases without making permanent changes to people's DNA.

    The trick: Edit RNA instead, the messenger that carries a gene's instructions.

    "If you edit RNA, you can have a reversible therapy," important in case of side effects, said Feng Zhang of the Broad Institute of MIT and Harvard, a gene-editing pioneer whose team reported the new twist Wednesday in the journal Science.

    A genome editing technique called CRISPR has revolutionized scientific research. It's a biological cut-and-paste tool that lets researchers spot a gene defect inside living cells and use molecular "scissors" to snip that spot, either deleting, repairing or replacing the affected gene.

    Researchers are using CRISPR to try to improve crops, develop malaria-resistant mosquitoes, grow transplantable organs inside animals, and develop treatments that one day may help genetic diseases such as sickle cell or muscular dystrophy.

    There are challenges for medical use. Because a change to DNA is permanent, accidentally cutting the wrong spot could lead to lasting side effects.

    And DNA repair is harder to achieve in certain cells, such as brain and muscle cells, than in others, such as blood cells — so targeting RNA may offer an important alternative, said University of California, San Diego, professor Gene Yeo, who wasn't involved in Wednesday's study. His team is creating its own RNA-targeting version of CRISPR.

    Disease can occur when a genetic defect leaves cells making too little or too much of a particular protein, or not making it at all.

    RNA, a cousin of DNA, carries the gene's instructions to start the protein-making process. Editing RNA's instructions should result in temporary fixes to abnormal protein production, Zhang explained. Because RNA degrades over time, the changes theoretically would last only as long as the therapy was used.

    To start figuring out how, researchers returned to nature.

    Kids at NM Compound Trained To Be Shooters: Prosecutors

    [NATL] Children at New Mexico Compound Trained To Be School Shooters: Prosecutors
    The suspected child abductor found last week with 11 children and four other adults at a squalid New Mexico compound had trained at least one of the minors to use an assault rifle in preparation for a school shooting, prosecutors said in court documents filed on Wednesday. 
     
    The children, who officials have said were between the ages of 1 and 15, were taken to the compound by some adults for the purpose of receiving weapons training for future acts of violence, the documents said.
    (Published Friday, Aug. 10, 2018)

    CRISPR was adapted for use in mammalian cells from a system that evolved in bacteria, and uses as its molecular scissors an enzyme named Cas9. Zhang's team examined relatives in the Cas protein family and found one, Cas13, that could target RNA instead. The researchers engineered a Cas13 variety so it sticks to RNA instead of cutting it. They then fused on another protein to edit that spot and tested it in lab dishes.

    The research is in its earliest stages, requiring more work before it even could be tested in animals.

    But San Diego's Yeo, who is using a different Cas approach to target RNA, praised the competing work.

    "It really tells us that many Cas proteins can truly bind RNA," he said. "The smart thing to do is to test a lot of them."